UBS (Lux) Equity Fund - Biotech (USD) P-acc: Branschfond, bioteknik: Fonden investerar globalt i företag som är inblandade i forskning, produktutveckling, tillverkning och/eller distribution inom biotekniksektorn.

Find our live Ubs (lux) Equity Fund - Biotech (usd) P-acc fund basic information. View & analyze the 0P00000AWI fund chart by total assets, risk rating, Min. investment, market cap and category.

UBS (Lux) Equity Fund Biotech (USD) P-acc Name of fund Fund features 1 Up until 31.12.2001 Lipper Peergroup UBS Equity Funds > UBS Sector Funds Investments in biotechnology equities worldwide UBS Equity Biotech Luxembourg edition Data as at end-February 2010 Fund description Actively managed equity portfolio investing globally in biotech companies Fondspreis für UBS (Lux) Equity Fund - Biotech (USD) Q-acc zusammen mit Morningstar Ratings und Research, Fondsperformance und Charts Anlageziel: UBS (Lux) Equity Fund - Biotech (USD) P-acc: UBS (Lux) Equity Fund – Biotech investiert hauptsächlich in Aktien und anderen Kapitalanteilen von Unternehmen, die schwergewichtig in der Forschung, Produktentwicklung, Produktherstellung und Vertrieb im Bereich Biotechnologie und verwandten Industriezweigen tätig sind. UBS (Lux) Equity Fund - Biotech (USD) Q-acc: Sektor - Bioteknologi, Aktier: Fonden investerer globalt i selskaber engageret i forskning, produkt udvikling, fremstilling og/eller distribution inden for den bioteknologiske sektor. UBS (Lux) Equity Fund – Biotech October 2010 UBS (Lux) Equity Fund – Biotech Page 2 Risk profile Subfund investments may be subject to substantial fluctuations and no guarantee can be given that the value of a unit will not fall below its value at the time of acquisition. UBS Global Allocation P BPGLX Morningstar Analyst Rating Quantitative rating as of Feb 28, 2021.

91, 364158, UBS (Lux) Equity Fund - Biotech P-acc, 13,711, 19,118, 32,829 Morningstar - ESG-Risk, ESG-Risk uppdaterad, Morningstar - låg UBS (Lux) EF Biotech (USD) P-acc (finns även i PPM) Bioteknikfond jämförs hos Morningstar mot indexet MSCI World/Biotechnology NR I slutet av förra veckan gick Morningstar Fund Awards av stapeln, där Morningstar UBS (Lux) Equity Fund – Biotech P-acc – 17,6 procent. Publicerat i Aktier | Märkt aktier, avanza, börs veckan, di, morningstar, privata krydda med ubs biotech,det har givit bra avkastning över tiden. 0,11 procent. Jonas Lindmark är analyschef på ratingföretaget Morningstar som betygsätter fonder. UBS (Lux) Equity Fund - Biotech (USD).

UBS (Lux) EF Biotech (USD) P-acc Morningstar Kategori™ Bransjefond, Bioteknologi Morningstar sin referanseindeks NASDAQ Biotechnology TR USD Benyttet i hele rapporten Fondets referanseindeks MSCI US IMI/Biotechnology NR USD Morningstar Rating™ QQQQ Investeringsprofil Fondet investerer globalt i selskaper som er beskjeftiget i

UBS Equity Biotech Performance Review UBS (Lux) Equity Fund - Biotech (USD) P-acc Performance (basis USD, net of fees)1-40-20 0 +20 +40 +60 +80 +100 +120-100 0 100 200 300 400 500 600 700 2009 UBS Sector Funds invest in equities and may therefore be subject to high fluctuations in value. UBS Equity Biotech P-acc Fund Fact Sheet UBS Equity Funds > UBS Sector Funds Fund description • Actively managed equity portfolio investing worldwide in biotech companies. • Efficient means of exploiting the potential of biotech companies operating in … 2021-02-18 2021-04-06 The latest fund information for UBS (Lux) Equity Fund - Biotech (USD) P Acc, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information. Fund price for UBS (Lux) Equity Fund - Biotech (USD) P-acc along with Morningstar ratings & research, long term fund performance and charts Fund price for UBS (Lux) Equity Fund - Biotech (USD) (SEK) P-acc along with Morningstar ratings & research, long term fund performance and charts Fund price for UBS (Lux) Equity Fund - Biotech (USD) Q-acc along with Morningstar ratings & research, long term fund performance and charts Fund prices, fact sheets, investment research, advice and portfolio tools for OEICs, unit trusts, ISAs, PEPs, ETFs, offshore, and life and pension funds 2020-06-23 · Prezzo di UBS (Lux) Equity Fund - Biotech (USD) P-acc, Rating e Analisi Morningstar, performance a breve e lungo termine e grafici.

Handla fonden UBS (Lux) EF Biotech (USD) P-acc hos oss. Vi har över 1200 fonder att välja bland. Bli kund gratis på 3 min med BankID!

Valor Liquidativo para el UBS (Lux) Equity Fund - Biotech (USD) Q-acc , Ratings Morningstar, análisis, rentabilidades a largo plazo y gráficos Handla fonden UBS (Lux) EF Biotech (USD) P-acc hos oss. Vi har över 1200 fonder att välja bland. Bli kund gratis på 3 min med BankID! Rahaston UBS (Lux) Equity Fund - Biotech (USD) P-acc kurssi, Morningstar rating ja analyysi, historiallinen tuotto ja kaavioita Fund price for UBS (Lux) Equity Fund - Biotech (USD) P-acc along with Morningstar ratings & research, long term fund performance and charts Performance charts for UBS Lux Equity Fund - Biotech USD (UBSEBIO) including intraday, historical and comparison charts, technical analysis and trend lines. UBS (Lux) EF Biotech (USD) I denna lista visas Morningstars Open Indexes. UBS Fund Management (Luxembourg) S.A. FondStorlek: 1064,18 milj USD .

Fund price for UBS (Lux) Equity Fund - Biotech (USD) P-acc along with Morningstar ratings & research, long term fund performance and charts. 17 feb 2021 Beleggingsdoelstelling: UBS (Lux) Equity Fund - Biotech (USD) P-acc: Opportunity (USD) P SGD acc met Morningstar ratings en analyses, Handla fonden UBS (Lux) EF Biotech (USD) P-acc hos oss. Vi har över 1200 fonder att välja bland.
Processutveckling - inspiration och metod

Journal of STOXX Issues Exclusive U.S. ETF License to UBS. Kaikki oleellinen rahastosta UBS (Lux) EF Biotech (USD) P-acc: Omistukset, kehitys, riskit ja luokitus.

1191730. EUR. -29.48 Währung Rendite. Morningstar. 4 Apr 2021 CURE · ETFS S&P Biotech ETF, -2.49, 14.42, 39.82, -- ETF · UBS IQ Morningstar Australia Quality ETF, -17.09, -17.28, -10.48, -0.14.
Ofri grund

hur gor man bouppteckning
37 an i himlen
knx utbildning stockholm
skriva intyg på dubbla lådor
betala lån i förtid swedbank

13 Nov 2019 UBS head of resources research Glyn Lawcock. Photo: Rob Homer. The major investment banks' sell-side research teams nervously met with

UBS (Lux) UBS Asian Smaller Companies. Fond. 5.21 %. Avkastn. i AXA IM Wave Framlington Biotech Fund Class A. Fond. -3.36 % All data levereras av Morningstar.